Published in Med Pediatr Oncol on January 01, 1984
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med (1998) 5.74
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med (1991) 5.22
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09
Monitoring for anthracycline cardiotoxicity. Pediatrics (1994) 4.05
Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med (1995) 4.03
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood (2001) 3.93
Development of homozygosity for chromosome 11p markers in Wilms' tumour. Nature (1984) 2.97
Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A (1993) 2.86
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med (1975) 2.71
BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science (1999) 2.54
Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation (1997) 2.34
A murine model of experimental metastasis to bone and bone marrow. Cancer Res (1988) 2.32
Results of treatment of 127 patients with systemic histiocytosis. Medicine (Baltimore) (1981) 2.17
Outcome of pregnancy in survivors of Wilms' tumor. JAMA (1987) 2.00
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia (2009) 1.99
Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol (1997) 1.98
Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J Pediatr Hematol Oncol (2000) 1.93
Radiation induced neoplasia following external beam therapy for children with retinoblastoma. Am J Roentgenol Radium Ther Nucl Med (1969) 1.88
Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium. Cancer (1997) 1.82
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene (2001) 1.82
Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med (1980) 1.78
Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood (1981) 1.77
Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol (1993) 1.65
Second malignancies in patients treated for childhood acute lymphoblastic leukemia. J Clin Oncol (1998) 1.63
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia (2000) 1.58
Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res (2000) 1.56
Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. Blood (1998) 1.55
Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer (1999) 1.52
Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52
Considerations in the radiation therapy of Wilms' tumor. Cancer (1973) 1.51
Risk of second tumors in survivors of childhood cancer. Cancer (1975) 1.51
B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest (1984) 1.51
Histiocytosis-X. N Engl J Med (1981) 1.51
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50
Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res (2000) 1.46
Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys (1993) 1.44
Subset derivation of T-cell acute lymphoblastic leukemia in man. J Clin Invest (1979) 1.44
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med (1986) 1.42
Cellular senescence in a cloned strain of bovine fetal aortic endothelial cells. Science (1980) 1.41
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res (1983) 1.39
[Nootropic drug evaluation for general practice]. Nervenarzt (1997) 1.39
The tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate enhances the proliferative response of Balb/c-3T3 cells to hormonal growth factors. J Cell Physiol (1979) 1.37
Roentgenologic aspects of Hodgkin's disease. II. Role of routine radiographs in detecting initial relapse. Cancer (1973) 1.37
In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. Cancer Res (1989) 1.37
Three-dimensional structure of Fab R19.9, a monoclonal murine antibody specific for the p-azobenzenearsonate group. Proc Natl Acad Sci U S A (1989) 1.35
Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med (1978) 1.35
Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol (2001) 1.33
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood (1996) 1.33
Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. J Clin Oncol (1998) 1.33
The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase. Oncogene (2000) 1.31
Radiation therapy for rhabdomyosarcoma of the orbit. Trans Am Acad Ophthalmol Otolaryngol (1969) 1.28
BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer (2006) 1.27
Synthesis of human plasminogen by the liver. Science (1980) 1.27
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J Clin Oncol (1994) 1.27
The role of radiotherapy in the treatment of malignant sweat gland neoplasms. Cancer (1990) 1.26
Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer (1998) 1.26
Treatment of plasma cell granuloma of the lung with radiation therapy. A report of two cases and a review of the literature. Cancer (1986) 1.24
Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene (2007) 1.24
Definitive radiation therapy of carcinoma of the prostate. A report on 15 years of experience. Radiology (1973) 1.23
Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia. J Clin Invest (1982) 1.21
Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial. J Neurooncol (1991) 1.20
Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy. Cancer (1973) 1.19
The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. J Clin Oncol (1992) 1.19
Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia. Cancer (2000) 1.18
BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene (1998) 1.18
Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood (1996) 1.16
Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. AJNR Am J Neuroradiol (1995) 1.15
Response of avian embryonic brain to spatially segmented x-ray microbeams. Cell Mol Biol (Noisy-le-grand) (2001) 1.15
Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv). Cancer Res (1992) 1.14
Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet (1994) 1.14
Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene (1997) 1.14
The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol (2001) 1.13
Modulation of HGF-induced tubulogenesis and branching by multiple phosphorylation mechanisms. Dev Biol (1993) 1.13
Radiation therapy in retinoblastoma. An analysis of 230 cases. Radiology (1969) 1.12
Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett (2001) 1.12
Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life. J Clin Oncol (1992) 1.12
Relationship of VH and VL genes encoding three idiotypic families of anti-p-azobenzenearsonate antibodies. Proc Natl Acad Sci U S A (1986) 1.11
Tumors of the exocrine pancreas in children and adolescents. A clinical and pathologic study of eight cases. Am J Surg Pathol (1983) 1.11
Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study. J Pediatr Hematol Oncol (2001) 1.10
Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene (1998) 1.10
Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest (1997) 1.10
Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet (1982) 1.10
Signal transduction in c-met mediated motogenesis. EXS (1993) 1.10
Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells. Breast Cancer Res Treat (2000) 1.09
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia. Lancet (1980) 1.09
Central nervous system neurocytoma and neuroblastoma in adults--report of eight cases. J Neurooncol (1990) 1.07
Radiation-induced angiosarcoma of the breast. Case report and review of the literature. Am J Clin Oncol (1994) 1.07
Pathogenesis of vertebral metastasis and epidural spinal cord compression. Cancer (1990) 1.06
The "typical" spine changes of sickle-cell anemia in a patient with thalassemia major (Cooley's anemia). Radiology (1967) 1.06
Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery (1995) 1.05
Proliferative characteristics of clonal endothelial cell strains. J Cell Physiol (1981) 1.05
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood (1997) 1.05
The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery (1991) 1.04
Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. Blood (1980) 1.04